A series of experts on the Chinese courts, patent attorneys, and other specialists have weighed in on the Apple versus Qualcomm battle, and believe that resolution through the system is well more than a year away, assuming that an agreement is not reached before then reports Bloomberg.
The task of deciding who prevails in a dispute that could affect a million workers falls to a relatively new arm of the country’s judiciary. The Beijing Intellectual Property Court is one of three specialist venues in the Chinese judiciary set up to rule exclusively on such cases.
Two weeks ago Qualcomm made its case seeking to ban production and sale of iPhones in China. That wouldhit Apple in its biggest overseas market and the country where most of its products are made.
According to Bloomberg, the Beijing IP Court handles patent, trademark and some administrative cases involving copyright and unfair competition, with the power to issue injunctions and award damages. Its verdicts can be appealed to the High Court in Beijing.
“Qualcomm may think it’s good timing to file the case as Apple is slowly declining here in China,” said Jin Di, an analyst at IDC. “Neither side is apparently backing down and the best solution could be going back to the negotiation table.”
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas